Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities

Precision dosing strategies require accounting for between‐patient variability in pharmacokinetics together with subsequent pharmacodynamic differences. Liquid biopsy is a valuable new approach to diagnose disease prior to the appearance of clinical signs and symptoms, potentially circumventing inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Achour, Brahim, Gosselin, Pauline, Terrier, Jean, Gloor, Yvonne, Al‐Majdoub, Zubida M., Polasek, Thomas M., Daali, Youssef, Rostami‐Hodjegan, Amin, Reny, Jean‐Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313840/
https://www.ncbi.nlm.nih.gov/pubmed/35262906
http://dx.doi.org/10.1002/cpt.2576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313840/
https://www.ncbi.nlm.nih.gov/pubmed/35262906
http://dx.doi.org/10.1002/cpt.2576

Ejemplares similares